L-Ornithine L-Aspartate Cas:3230-94-2
Helu Helu | XD91158 |
inoa mea kūʻai | L-Ornithine L-Aspartate |
CAS | 3230-94-2 |
ʻĀpana Molekala | C9H19N3O6 |
Kaumaha Molecular | 265.26 |
Nā kikoʻī mālama | 2 a 8 °C |
Kānāwai Kūʻai Kūlike | 29224985 |
Huahana Huahana
Ka nana aku | ʻO ka pauka kristal keʻokeʻo |
ʻO Assay | >99% |
Kahuli kiko'ī | +27 +/-1 |
Nā metala kaumaha | <0.001% |
pH | 6 - 7 |
Nalo ma ka maloo | <7% |
Koena ma ka Ignition | <0.2% |
Mokuaina o ka hooponopono | Akaka |
ʻO Ornithine aspartate ka lāʻau lapaʻau mua i hoʻohana ʻia i ka mālama ʻana i ka hangover a me ka encephalopathy hepatic.Me ka hōʻiliʻili ʻana o ka ʻike noiʻi noiʻi, ua hoʻohana nui ʻia ka ornithine aspartate i ka mālama ʻana i nā maʻi o ka ate, a ua loaʻa i nā hopena curative pololei i ka encephalopathy hepatic, nā lāʻau hōʻino o ka ate, ka momona momona, ka maʻi hepatitis a me nā maʻi ʻē aʻe. ʻike ʻia e nā kauka lapaʻau.
Hāʻawi ʻo Ornithine aspartate i kahi substrate no ka urea a me ka glutamine synthesis in vivo.ʻO Glutamine ka huahana detoxification o ka amonia, a me ka mālama ʻana a me ka lawe ʻana o ka ammonia.Ma lalo o nā kūlana physiological a me pathological, hoʻopili ʻia ka synthesis o ka urea a me ka synthesis o ka glutamine e ka ornithine, aspartic acid a me nā pūhui dicarboxyl ʻē aʻe.Hoʻokomo ʻia ʻo Ornithine i ke kaʻina holoʻokoʻa o ka hoʻāla ʻana o ka pōʻai urea a me ka detoxification o ka amonia.Hoʻokumu ʻia ʻo Arginine i kēia kaʻina hana, a laila hoʻokaʻawale ʻia ka urea e hana i ka ornithine.Hoʻokomo ka ʻakika Aspartic i ka synthesis o ka waikawa nucleic i nā hepatocytes e hoʻomaʻamaʻa i ka hoʻoponopono ʻana i nā hepatocytes i pōʻino.Eia kekahi, ma muli o ka hoʻolaha indirect o ka aspartic acid ma ke kaʻina metabolic o ka tricarboxylic acid cycle i loko o nā pūnaewele o ka ate, hoʻolaha ia i ka synthesis ikehu i loko o nā pūnaewele ate, kahi e hoʻomaikaʻi ai i ka hoʻoponopono ʻana i nā puʻupuʻu i hōʻino ʻia a wikiwiki i ka hoʻihoʻi ʻana o ka hana ate.Ua hōʻike ʻia ka holomua hou e hiki i ka aspartate ke kāohi i ka hana o nā inflammasomes ma o N-methyl-D-aspartate (NMDA) receptors, a laila e hōʻemi ana i ke ʻano pharmacological o ka pane ʻana o ka ate.ʻO nā mea hoʻokipa NMDA he subtype o ka ionotropic excitatory glutamate receptors, kahi mea koʻikoʻi i nā kaʻina physiological e like me ka synaptic transmission, synaptic plasticity, ke aʻo ʻana a me ka hoʻomanaʻo ʻana i ka ʻōnaehana nerve waena.Ua hōʻoia ʻia nā haʻawina pathological ma hope mai ua hoʻomaikaʻi maikaʻi ka aspartate i nā ʻeha ʻeha i loko o ke ake.
Hoʻohana lapaʻau
Ma ke kahua o ka maʻi ate: Ornithine aspartate ua hoʻohana nui ʻia e like me ka lāʻau anti-inflammatory a me ka hepatoprotective i ka mālama ʻana i nā maʻi like ʻole o ka ate, e like me ka encephalopathy hepatic, ka lāʻau hōʻino o ka ate, ka momona momona, ka maʻi hepatitis, etc. ʻO ka amonia koko i nā mea maʻi me ka encephalopathy a me ka hoʻomaha ʻana i nā hōʻailona neuropsychiatric e lilo mālie i ka lāʻau lapaʻau koʻikoʻi no ka mālama ʻana i nā maʻi like ʻole.
ʻO Ornithine aspartate kahi substrate koʻikoʻi no ka synthesis o ka urea a me ka glutamine.Hiki i ka Ornithine ke hoʻoikaika i nā enzymes nui i ke kaʻina hana o ka urea synthesis - ornithine carbamoyltransferase a me ka carbamoyl phosphate synthase, a hoʻoikaika i ka ammonia Metabolism e hoʻokō i ka detoxification o ke koko amonia, aspartic acid ma ke ʻano he substrate hiki ke hana i ka glutamic acid a me ka oxaloacetic acid, ʻo glutamine ka huahana detoxification o ammonia, a ʻo ia hoʻi ka mālama ʻana a me ka lawe ʻana i ka amonia.Hoʻokomo ʻo Oxaloacetate i ka pōʻai tricarboxylic acid, hoʻolalelale i ka hana ʻana o ka ikehu i loko o nā pūnaewele ate, a hiki ke hoʻoponopono ʻia, hoʻoponopono hou ʻia, a hoʻihoʻi i ka hana ate.Hiki i ka Ornithine aspartate ke hoʻomaikaʻi maikaʻi i ka hana o ka ate, hoʻemi i ke koko amonia, a me ka synergistically hōʻemi i ka amonia me ka lactulose a me ka ofloxacin, no laila e hoʻomaikaʻi nui ai i ka lāʻau lapaʻau o ka encephalopathy hepatic, i kūpono i ka noi lapaʻau.
Oncology: Me ka hoʻololi mau ʻana i nā ʻano a me nā ʻano o nā lāʻau lapaʻau chemotherapy, ke kū mai nei nā pilikia e pili ana i nā lāʻau lapaʻau chemotherapy, a ʻo ka pōʻino o ka ate kekahi o nā pōʻino maʻamau.Ke hiki mai ka poino o ke akepa'a, e pili ana ia i ke ola kino a me ka no'ono'o o ka poe ma'i i na degere like ole, keakea i ka hoohana ana i ka chemotherapy regimens, a e hoonawaliwali i ka hopena therapeutic o ka chemotherapy.I nā hihia koʻikoʻi, hiki ke hoʻoweliweli i ke ola o ka hāʻule ʻana o ka ate.Hiki i ka Ornithine aspartate ke hoʻomaikaʻi nui i ka pōʻino o ka ate i hoʻokumu ʻia e nā lāʻau lapaʻau chemotherapy a hoʻomaikaʻi i ka hopena therapeutic o nā maʻi maʻi.
Kahua hana ʻoki: ʻO ka hana ʻokiʻoki he mea ia i nā ʻāpana kino holoʻokoʻa o ka mea maʻi, a ʻo ka pōʻino o ka ate ma hope o ka hana ʻana he pilikia maʻamau.Hiki i ka Ornithine aspartate ke pale a mālama i ka pōʻino o ka ate ma hope o ka hana a hoʻoikaika i ka hoʻihoʻi hou ʻana o nā maʻi.